
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells
Peter A. C. Wing, Thomas P. Keeley, Xiaodong Zhuang, et al.
Cell Reports (2021) Vol. 35, Iss. 3, pp. 109020-109020
Open Access | Times Cited: 90
Peter A. C. Wing, Thomas P. Keeley, Xiaodong Zhuang, et al.
Cell Reports (2021) Vol. 35, Iss. 3, pp. 109020-109020
Open Access | Times Cited: 90
Showing 1-25 of 90 citing articles:
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Innate immunological pathways in COVID-19 pathogenesis
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 164
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 164
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Yanchun Peng, Suet Ling Felce, Danning Dong, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 50-61
Open Access | Times Cited: 158
Yanchun Peng, Suet Ling Felce, Danning Dong, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 50-61
Open Access | Times Cited: 158
Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C
Claudia Vollbracht, Karin Kraft
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 111
Claudia Vollbracht, Karin Kraft
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 111
Illuminating RNA biology through imaging
Phuong Le, Noorsher Ahmed, G Yeo
Nature Cell Biology (2022) Vol. 24, Iss. 6, pp. 815-824
Open Access | Times Cited: 78
Phuong Le, Noorsher Ahmed, G Yeo
Nature Cell Biology (2022) Vol. 24, Iss. 6, pp. 815-824
Open Access | Times Cited: 78
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Xiaoyi Yuan, Wei Ruan, Bentley J. Bobrow, et al.
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 3, pp. 175-200
Closed Access | Times Cited: 68
Xiaoyi Yuan, Wei Ruan, Bentley J. Bobrow, et al.
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 3, pp. 175-200
Closed Access | Times Cited: 68
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 103
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 103
Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions
Laís Passariello Pral, José Luís Fachi, Renan Oliveira Corrêa, et al.
Trends in Immunology (2021) Vol. 42, Iss. 7, pp. 604-621
Open Access | Times Cited: 91
Laís Passariello Pral, José Luís Fachi, Renan Oliveira Corrêa, et al.
Trends in Immunology (2021) Vol. 42, Iss. 7, pp. 604-621
Open Access | Times Cited: 91
Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 56
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 56
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences
Young Seok Lee, Peter A. C. Wing, Dalia Gala, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 51
Young Seok Lee, Peter A. C. Wing, Dalia Gala, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 51
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia
Hannah Lawson, James P. Holt‐Martyn, Vilma Dembitz, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 916-937
Open Access | Times Cited: 13
Hannah Lawson, James P. Holt‐Martyn, Vilma Dembitz, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 916-937
Open Access | Times Cited: 13
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
iScience (2021) Vol. 24, Iss. 10, pp. 103144-103144
Open Access | Times Cited: 51
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
iScience (2021) Vol. 24, Iss. 10, pp. 103144-103144
Open Access | Times Cited: 51
Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Mengqiu Miao, Mengqiu Wu, Yuting Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Mengqiu Miao, Mengqiu Wu, Yuting Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome
Senko Tsukuda, James Michael Harris, Andrea Magrì, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011917-e1011917
Open Access | Times Cited: 7
Senko Tsukuda, James Michael Harris, Andrea Magrì, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011917-e1011917
Open Access | Times Cited: 7
Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform
George Mpekoulis, Efseveia Frakolaki, Styliani Τaka, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253458-e0253458
Open Access | Times Cited: 33
George Mpekoulis, Efseveia Frakolaki, Styliani Τaka, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253458-e0253458
Open Access | Times Cited: 33
Roxadustat: do we know all the answers?
Qiuyu Li, Qian-Wen Xiong, Xuefeng Yao, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 14
Qiuyu Li, Qian-Wen Xiong, Xuefeng Yao, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 14
HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
Hongbing Yang, Hong Sun, Simon Brackenridge, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 14
Hongbing Yang, Hong Sun, Simon Brackenridge, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 14
Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome
Haiqi Xu, Linzhen Kong, Jingfei Cheng, et al.
Nature Methods (2024) Vol. 21, Iss. 11, pp. 2024-2033
Open Access | Times Cited: 6
Haiqi Xu, Linzhen Kong, Jingfei Cheng, et al.
Nature Methods (2024) Vol. 21, Iss. 11, pp. 2024-2033
Open Access | Times Cited: 6
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein
Xiafei Wei, Yuzheng Zhou, Xiaotong Shen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2505-2519
Open Access | Times Cited: 5
Xiafei Wei, Yuzheng Zhou, Xiaotong Shen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2505-2519
Open Access | Times Cited: 5
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate
Endika Prieto‐Fernández, Leire Egia‐Mendikute, Laura Vila, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 1065-1076
Open Access | Times Cited: 29
Endika Prieto‐Fernández, Leire Egia‐Mendikute, Laura Vila, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 1065-1076
Open Access | Times Cited: 29
SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
Pooja Shivshankar, Harry Karmouty‐Quintana, Tingting Mills, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1430-1449
Open Access | Times Cited: 22
Pooja Shivshankar, Harry Karmouty‐Quintana, Tingting Mills, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1430-1449
Open Access | Times Cited: 22
Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome
Haiqi Xu, Linzhen Kong, Jingfei Cheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Haiqi Xu, Linzhen Kong, Jingfei Cheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model
Peter A. C. Wing, Maria Prange‐Barczynska, Amy Cross, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010807-e1010807
Open Access | Times Cited: 18
Peter A. C. Wing, Maria Prange‐Barczynska, Amy Cross, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010807-e1010807
Open Access | Times Cited: 18
Christopher Anthony Denaro, Yara I. Haloush, Samuel Yien Hsiao, et al.
Aging Cell (2022) Vol. 21, Iss. 11
Open Access | Times Cited: 18